Navigation Links
Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
Date:8/27/2009

Mennen Medical, a leading provider of patient monitors, cardiac catheterization and electrophysiology systems, announced today that the global growth consulting company Frost & Sullivan has awarded Mennen Medical the 2009 European Patient Monitoring Technology Leadership of the Year Award for CIPAM development.

Southampton, PA (PRWEB) August 27, 2009 -- Mennen Medical, a leading provider of patient monitors, cardiac catheterization and electrophysiology systems, announced today that the global growth consulting company Frost & Sullivan has awarded Mennen Medical the 2009 European Patient Monitoring Technology Leadership of the Year Award for Cipam development

This prestigious award is bestowed upon the company that has demonstrated excellence in technology leadership within their industry.

Frost & Sullivan presented the "2009 European Patient Monitoring Technology Leadership of the Year Award" to Mennen Medical for its innovative and advanced technological platform - the CIPAM, which is being used by Mennen Medical in its patient monitors and hemodynamic applications.

The CIPAM (Configurable Isolated Physiological Acquisition Module) is Mennen's front end board, which features multiple acquisition units for measuring various physiological parameters. The technological advantage of the CIPAM is based on several years of development, resulting in a single board that includes all parameters' acquisition components. This enables a development of a wide range of new products which are compact and sizable and yet have the same powerful abilities of the current multiple boards which are used by other manufacturers.

Mennen Medical has already developed applications with the CIPAM, among them the CFE, which is the front end of Mennen Medical's hemodynamic system, the VitaLogik 4X00, which is a portable compact patient monitor and the VitaLogik 5X00 - a mid range bed side monitor. All these applications have gained FDA and CE clearances. Mennen Medical is planning to launch the VitaLogik 6X00 patient monitor by the end of 2009 - which is expected to be the leading "member" in the VitaLogik family.

The VitaLogik bed-side patient monitoring line is considered to be a high end line of products which provide a reliable and wide solution for critical to intermediate care patients from neonates to adults.

By introducing the newly developed CIPAM board, Mennen Medical has established a new platform that will lead the way for the next generation of Mennen Medical's patient monitoring line, which is currently being developed by the company's R&D team.

Mennen Medical's President, Erez Nimrod, stated: "It is our strategy to constantly strive for high quality devices with innovative technologies. We are very proud to have this most modern technology which is the basis for our entire monitoring product line and honored by its recognition by Frost and Sullivan. Since the successful introduction of the CIPAM we have already started the development of our next generation - the CIPAM Pro which will be based on Motorola's latest advanced OMAP 3 technology. This will be introduced to the market, during 2010, together with new, state of the art products, and therefore expand our product variety. I have no doubt that the high quality of our existing devices and the new products being released, will assure Mennen Medical's continuation as a leader of new technologies and innovations."

About Mennen Medical:
Mennen Medical is a leading international corporation, developing and marketing cardiac catheterization and electrophysiology systems, patient monitoring, clinical data information solutions and thermoregulation products. For over four decades, Mennen has led these fields worldwide, combining cutting edge technological achievements with an uncompromising corporate culture of passionate customer service and personalized care. Mennen Medical is a privately owned company, with offices in Israel, the US and the UK.

For additional information:
United States and Canada call: 215 259 1020
All other regions call: + 972 8 932 3333
Mennen Medical

About Frost & Sullivan:
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit Frost & Sullivan.

Frost & Sullivan Contact:
Jasmine Malone - Promotions Coordinator
Phone: 0044 207 915 7869

###

Read the full story at http://www.prweb.com/releases/mennen/cipam/prweb2795494.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. LUMEDX and Mennen Medical(R) Announce Agreement for a Strategic Cooperation
2. Council for American Medical Innovation Honors Health Champion Senator Edward M. Kennedy
3. Medical Scans a Significant Source of Radiation
4. Home Delivery Medical Launches New Division For Sleep Centers
5. ReBuilder Medical Technologies, Inc. Announces New York Marketing Agreement
6. VA Continues Gulf War Research, Cancels Contract with UTSW Medical Center
7. Solta Medical Launches New Fraxel re:store(R) Dual Laser System
8. Dr. Michael Barry of MGH is New President of Foundation for Informed Medical Decision Making
9. Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime, Anywhere Access to Patient Data and Communications
10. Environmental Tectonics Corporations BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania
11. ReBuilder Medical Technologies, Inc. Announces First Quarter 2009 is Profitable
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
(Date:9/20/2017)... Houston, Texas (PRWEB) , ... September 20, 2017 ... ... leader in the Orthodontics and Clear Aligner clinical and commercial support services market) ... School of Dentistry (PGSD) in Sydney, Australia. , The PGSD is the ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time since going ... receiving positive feedback from customers trying the product for the first time, and others ... was developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at risk from ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Americans at risk of price gouging for their prescription drugs, according to a ... “Because Medicare isn’t negotiating on our behalf, there’s no consistency in drug pricing ...
(Date:9/20/2017)... ... , ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION”: A ... is the creation of published author, Bill Miller. Bill Miller has a ... more than a decade of addiction to prescription drugs. He has a ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Psalms of Humidity”: is a fascinating depiction of ... the readers one step closer to God. “Psalms of Humidity” is the creation of ... have been made within his life are the very same things that have shaped ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 6, 2017  Medical professionals are expected ... while treating their patients. Medical simulations offer ... involving patients. Simulation provides a safe method ... out procedures, refine techniques and build confidence, ... new technology, such as augmented reality, will ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a ... created a vibrant charitable donation program -- "Color ... support congenital heart defect research by The Children,s ... and the general public are encouraged to download ... submit the completed artwork to the gallery on ...
Breaking Medicine Technology: